Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%
CNBC
Tue, 04/29/25 - 08:23 am
Tags:
Novo Nordisk, Hims & Hers Health, Ro, Life MD, telehealth, Wegovy, obesity
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
Fierce Pharma
Fri, 04/25/25 - 11:32 am
Tags:
Novo Nordisk, legal, semaglutide, drug compounding
Novo says it’s submitted obesity pill for FDA approval
BioPharma Dive
Mon, 04/21/25 - 06:13 pm
Tags:
Novo Nordisk, Wegovy, obesity, oral Wegovy, FDA
Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts
Fierce Pharma
Thu, 04/17/25 - 11:06 pm
Tags:
diabetes, obesity, Eli Lilly, Novo Nordisk, BMO Capital Markets
Novo Nordisk warns consumers about counterfeit versions of Ozempic in US
Investing.com
Mon, 04/14/25 - 07:19 pm
Tags:
Novo Nordisk, Ozempic, drug counterfeiting
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
Yahoo Finance
Wed, 04/9/25 - 11:18 am
Tags:
Novo Nordisk, Brazil, drug manufacturing, GLP-1 agonists
HHS leaves door open to future Medicare coverage of obesity drugs
BioSpace
Tue, 04/8/25 - 11:54 am
Tags:
HHS, Medicare, obesity, Eli Lilly, Novo Nordisk
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
CNBC
Sun, 04/6/25 - 11:40 pm
Tags:
Donald Trump, Medicare, obesity, GLP-1 agonist, Eli Lilly, Novo Nordisk
Novo Holdings nearly doubles earnings as Wegovy swells coffers
Yahoo/Reuters
Wed, 04/2/25 - 11:43 am
Tags:
Novo Holdings, earnings, Wegovy, Novo Nordisk
ACC25: Ozempic shows its value in PAD
Pharmaphorum
Mon, 03/31/25 - 10:03 am
Tags:
Novo Nordisk, Ozempic, type 2 diabetes, diabetes, PAD, ACC
Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide
Fierce Biotech
Fri, 03/28/25 - 11:24 am
Tags:
Lexicon Pharmaceuticals, Novo Nordisk, obesity, semaglutide
BofA cuts Novo Nordisk shares target on expected Q1 earnings miss
Yahoo Finance
Fri, 03/28/25 - 11:22 am
Tags:
Novo Nordisk, earnings, Wegovy, Ozempic
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Fierce Biotech
Mon, 03/24/25 - 11:20 am
Tags:
Novo Nordisk, obesity, United Laboratories, triple G agonists, UBT251
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Fierce Pharma
Mon, 03/24/25 - 11:05 am
Tags:
Novo Nordisk, Wegovy, NovoCare Pharmacy, obesity
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
MSN/Reuters
Mon, 03/24/25 - 11:02 am
Tags:
Hypera Pharma, semaglutide, generics, Ozempic, Novo Nordisk
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Mon, 03/24/25 - 10:58 am
Tags:
Eli Lilly, Novo Nordisk, obesity, DTC, Mounjaro, Wegovy
'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up
Fierce Biotech
Thu, 03/20/25 - 11:17 am
Tags:
Novo Nordisk, R&D, layoffs
Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial
MSN/Reuters
Thu, 03/20/25 - 10:18 am
Tags:
Eli Lilly, Mounjaro, India, weight loss, Novo Nordisk
How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight
Yahoo/Reuters
Thu, 03/13/25 - 11:38 am
Tags:
Novo Nordisk, Novo Nordisk Foundation
Novo Nordisk's Ozempic successor disappointed Wall Street again
Yahoo Finance
Mon, 03/10/25 - 11:13 am
Tags:
Novo Nordisk, obesity, CagriSema, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.